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The United Nations predicts that the current world population
of 7.2 billion is projected to reach 9.6 billion by 2050, which can
only mean one thing for global agriculture, and that is increased
pressure on production. One step to increase food supply is the
abolition of the milk quota restrictions in the EU in 2015. It is
inevitable with expansion and intensification of production that
risks associated with disease will be exacerbated. This will have
critical consequences for the sustainability of farming systems, for
the safety of the food chain, and for human health. In this context,
it is appropriate that we redouble every effort to understand the
immune response, particularly to recalcitrant infectious diseases
in cattle.
The publication of the bovine genome in 2009 and the advent
of new high-throughput technologies have facilitated a massive
expansion in our knowledge of the immune response in cat-
tle. Genomic selection means we can now identify animals with
superior genetics at birth and use them as parents of the next gen-
eration, thereby rapidly increasing the rate of genetic gain. While
these methods are currently in use to breed cattle with superior
genetics for production traits, they are not yet available to improve
disease resistance. Mycobacterial and mammary gland (Mastitis)
infections represent two diseases that severely impact global cat-
tle production, with an annual estimated cost of $3 billion for
TB globally (1) and multiples of this value for mastitis, especially
when the costs associated with subclinical infection are included
(2, 3). Both these diseases, as well as complementary analyses on
the regulation of bovine immunity, are addressed by cutting edge
papers in this edition of Frontiers.
Mycobacterium tuberculosis causes TB in human beings and
over one-third of the world’s population are infected with this
disease. Similarly, in cattle, related mycobacterial species cause
potentially zoonotic infections, which are endemic in many parts
of the world, despite stringent global surveillance and control
programs. The advent of Next-Generation Sequencing (NGS)
technologies holds significant promise to overcome limitations in
current generation test sensitivity and specificity and as discussed
by McLoughlin et al., transcript biomarker signatures have been
identified, which discriminate between TB patients with active and
latent disease. Indeed, McLoughlin et al. used multi-dimensional
scaling to unambiguously classify peripheral blood leukocyte tran-
scriptomic profiles from Mycobacterium bovis infected and healthy
cattle, thereby uncovering potential biomarkers for M. bovis infec-
tion (4). This technology is a powerful tool for unraveling the
complexities of host immune response and provides new layers of
information, which deepens our understanding of host–pathogen
interactions that underlie Mycobacterial disease pathogenesis. The
macrophage is recognized as the key effector cell driving anti-
mycobacterial immunity but which can be hijacked by mycobac-
teria, thereby contributing to suboptimal bacterial clearance and
disease chronicity. Using the macrophage as a model, RNA-seq
was performed after challenge with Mycobacterium avium sub-
species paratuberculosis (MAP), which has uncovered novel genes
that have not previously been associated with the host response
to MAP infection (5). One of the key challenges with NGS tech-
nologies is the bioinformatic analysis to extract meaningful and
biologically relevant findings from the wealth of data generated.
Sophisticated system-biology tools have been employed by Killick
et al. to generate biological interaction networks that usefully iden-
tify key hub and bottleneck genes that are central to the immune
response and thereby potential targets for immunomodulation –
either naturally by pathogens in their eternal quest for survival, or
therapeutically with the development of new intervention strate-
gies (6). Furthermore, a comparative analysis of the macrophage
response to various strains of mycobacteria has been reviewed;
M. bovis induced a distinct transcriptional profile in monocyte-
derived macrophages compared to the more similar profiles of
both M. bovis BCG and MAP (7). The authors describe how dif-
ferential expression of type-I interferon genes were specific to the
virulent M. bovis strain supporting a role for these genes in the
establishment of active tuberculosis in cattle.
The identification of the genes and pathways involved in orches-
tration of the immune response is not merely of fundamental
importance but differentiating between the immune responses to
closely related bacterial species can have very real implications
for the success of current generation diagnostics. The study by
Kennedy et al., examines the effects of annual mandatory test-
ing for M. bovis infection on the ELISA performance routinely
used for the diagnosis of MAP (8). In one herd, prior to testing
for bovine tuberculosis (BTB), 7.9% of cattle serum samples and
5.8% of milk samples were positive for MAP antibodies. Shortly
after the BTB test, the MAP ELISA positive rate increased to 39%
in both sample types, clearly showing BTB test interference in
MAP ELISA performance. Exploiting differences in host immunity
induced in response to these closely related strains of mycobacteria
could yield significant dividends in terms of increased specificity
of diagnostics.
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An optimal and effective host immune response must overcome
pathogen-mediated efforts to subvert it while minimizing tissue
damage and, therefore, the regulation of the immune response
is critical. Furthermore, shedding light on the differential dialog
between the host and pathogenic or comensal bacterial strains
is a very exciting area of research. It is of interest, therefore,
that Villena et al. review how immunobiotics can dampen TLR-
mediated inflammation in an intestinal cell line, and postulate how
immunoregulatory feeds could be developed in the future (9).
Inflammation is a feature of most diseases, and detailed knowl-
edge on the pathways regulating it is critical toward developing
effective immunoregulatory approaches in cattle. MiRNAs have
also been shown to be powerful regulators of immunity and as
reviewed by Lawless et al., 793 miRNAs have been identified to
date in the bovine genome (10). Their rapid induction in response
to challenge and the tissue-specific expression pattern of some
has led to speculation on their potential use as diagnostics. Work
by the same group has identified miRNA signatures of infection
in mammary epithelial cells in response to a common mastitis-
causing pathogen. The review highlights relevant studies on how
miRNAs regulate the production of IFN-y and TNF, key cytokines
in the immune response to TB.
In a comprehensive review, Thompson-Crispi et al. integrates
multiple studies on the genetic regulation of the bovine immune
response, particularly in relation to mastitis (11). Interestingly, the
review discusses earlier work by the same group in which their
High Immune Response (HIR) technology was used to identify
Immunity+ sires, daughters of which showed a 44% reduction
in mastitis as well as reduced susceptibility to other diseases. The
potential consequences of selection for a specific immune phe-
notype are discussed, and the review signposts how integration
of complementary genetic, genomic, and epigenetic data – sup-
plemented with accurate disease and health phenotype informa-
tion – will enhance our ability to breed cattle with superior disease
resistance in the future.
Early fetal mortality is a major contributory factor to poor
reproductive outcomes and increased costs, especially in high
producing dairy cows. In that regard, the review by Fair is a
relevant one. Although immunological analyses in the cow dur-
ing pregnancy are growing, attempts to evaluate the interaction
between the cow and the developing fetus are few. While com-
parative immunology can shed some light, Fair argues that basic
understanding in the bovine are required to more comprehen-
sively understand the complex regulation of local and systemic
immunity in the pregnant cow and thereby yield novel solutions
to fertility problems (12). Understanding the immune shifts that
occur during pregnancy is also critical to understanding the win-
dows of susceptibility that may exist through which susceptibility
to infectious diseases could be increased.
Multi-factorial challenges, for example achieving and sustain-
ing excellent animal health, require multifaceted solutions that
can only be achieved through intensive integration of knowledge
and expertise from a diverse spectrum of research efforts (13). As
the physicist Richard J. Feynman once wrote “In order to make
progress, one must leave the door to the unknown ajar.” There is a
lot yet to learn in relation to bovine immunity and, therefore, this
e-book is a timely integration of the most current research and
scientific thinking on these critical issues and will contribute to
the direction of future research in these areas. When dealing with
infectious diseases, the old truism is perfectly apt – ipsa scientia
potestas est. New knowledge also prepares us for the unforeseen
challenges of the future.
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